176 related articles for article (PubMed ID: 25150698)
1. Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy.
Xiao L; Harihar S; Welch DR; Zhou A
Anal Chim Acta; 2014 Sep; 843():73-82. PubMed ID: 25150698
[TBL] [Abstract][Full Text] [Related]
2. Surface-enhanced Raman spectroscopy (SERS) nanoprobes for ratiometric detection of cancer cells.
Li L; Liao M; Chen Y; Shan B; Li M
J Mater Chem B; 2019 Feb; 7(5):815-822. PubMed ID: 32254856
[TBL] [Abstract][Full Text] [Related]
3. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
[TBL] [Abstract][Full Text] [Related]
4. Gd
Xiao L; Tian X; Harihar S; Li Q; Li L; Welch DR; Zhou A
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jun; 181():218-225. PubMed ID: 28365452
[TBL] [Abstract][Full Text] [Related]
5. Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.
Wang J; Liang D; Feng J; Tang X
Anal Chem; 2019 Sep; 91(17):11045-11054. PubMed ID: 31361124
[TBL] [Abstract][Full Text] [Related]
6. Unveiling NIR Aza-Boron-Dipyrromethene (BODIPY) Dyes as Raman Probes: Surface-Enhanced Raman Scattering (SERS)-Guided Selective Detection and Imaging of Human Cancer Cells.
Adarsh N; Ramya AN; Maiti KK; Ramaiah D
Chemistry; 2017 Oct; 23(57):14286-14291. PubMed ID: 28796314
[TBL] [Abstract][Full Text] [Related]
7. Use of surface-enhanced Raman scattering to quantify EGFR markers uninhibited by cetuximab antibodies.
Chung E; Lee J; Yu J; Lee S; Kang JH; Chung IY; Choo J
Biosens Bioelectron; 2014 Oct; 60():358-65. PubMed ID: 24859273
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of immunomarkers in vivo via multiplexed surface enhanced Raman spectroscopy with gold nanostars.
Ou YC; Webb JA; O'Brien CM; Pence IJ; Lin EC; Paul EP; Cole D; Ou SH; Lapierre-Landry M; DeLapp RC; Lippmann ES; Mahadevan-Jansen A; Bardhan R
Nanoscale; 2018 Jul; 10(27):13092-13105. PubMed ID: 29961778
[TBL] [Abstract][Full Text] [Related]
9. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study.
Wu Y; McEwen GD; Harihar S; Baker SM; DeWald DB; Zhou A
Cancer Lett; 2010 Jul; 293(1):82-91. PubMed ID: 20083343
[TBL] [Abstract][Full Text] [Related]
10. A clinically feasible diagnostic spectro-histology built on SERS-nanotags for multiplex detection and grading of breast cancer biomarkers.
Murali VP; Karunakaran V; Murali M; Lekshmi A; Kottarathil S; Deepika S; Saritha VN; Ramya AN; Raghu KG; Sujathan K; Maiti KK
Biosens Bioelectron; 2023 May; 227():115177. PubMed ID: 36871528
[TBL] [Abstract][Full Text] [Related]
11. Sea-urchin-like Au nanocluster with surface-enhanced raman scattering in detecting epidermal growth factor receptor (EGFR) mutation status of malignant pleural effusion.
Wang L; Guo T; Lu Q; Yan X; Zhong D; Zhang Z; Ni Y; Han Y; Cui D; Li X; Huang L
ACS Appl Mater Interfaces; 2015 Jan; 7(1):359-69. PubMed ID: 25495142
[TBL] [Abstract][Full Text] [Related]
12. Sensing of p53 and EGFR Biomarkers Using High Efficiency SERS Substrates.
Owens P; Phillipson N; Perumal J; O'Connor GM; Olivo M
Biosensors (Basel); 2015 Oct; 5(4):664-77. PubMed ID: 26516922
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing breast cancer cells using surface-enhanced Raman scattering.
Yang J; Wang Z; Zong S; Song C; Zhang R; Cui Y
Anal Bioanal Chem; 2012 Jan; 402(3):1093-100. PubMed ID: 22124755
[TBL] [Abstract][Full Text] [Related]
14. Application of surface enhanced Raman spectroscopy as a diagnostic system for hypersialylated metastatic cancers.
Shashni B; Horiguchi Y; Kurosu K; Furusho H; Nagasaki Y
Biomaterials; 2017 Jul; 134():143-153. PubMed ID: 28460336
[TBL] [Abstract][Full Text] [Related]
15. Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines.
Spaziani S; Esposito A; Barisciano G; Quero G; Elumalai S; Leo M; Colantuoni V; Mangini M; Pisco M; Sabatino L; De Luca AC; Cusano A
J Nanobiotechnology; 2024 Jun; 22(1):350. PubMed ID: 38902746
[TBL] [Abstract][Full Text] [Related]
16. Wide-field multiplexed imaging of EGFR-targeted cancers using topical application of NIR SERS nanoprobes.
Mallia RJ; McVeigh PZ; Fisher CJ; Veilleux I; Wilson BC
Nanomedicine (Lond); 2015 Jan; 10(1):89-101. PubMed ID: 25046405
[TBL] [Abstract][Full Text] [Related]
17. Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.
Jokerst JV; Miao Z; Zavaleta C; Cheng Z; Gambhir SS
Small; 2011 Mar; 7(5):625-33. PubMed ID: 21302357
[TBL] [Abstract][Full Text] [Related]
18. Template-Assisted Plasmonic Nanogap Shells for Highly Enhanced Detection of Cancer Biomarkers.
Kang H; Jeong S; Yang JK; Jo A; Lee H; Heo EH; Jeong DH; Jun BH; Chang H; Lee YS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578653
[TBL] [Abstract][Full Text] [Related]
19. SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.
Lyu N; Pedersen B; Shklovskaya E; Rizos H; Molloy MP; Wang Y
Exploration (Beijing); 2022 Jun; 2(3):20210176. PubMed ID: 37323700
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S
BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
